Growth Profiles of Children and Adolescents Living with and without Perinatal HIV Infection in Southern Africa: A Secondary Analysis of Cohort Data.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
28 Oct 2023
Historique:
received: 11 09 2023
revised: 15 10 2023
accepted: 21 10 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Impaired linear growth and slower pubertal growth can be associated with perinatal HIV infection. We characterised growth relative to population norms, among the full adolescent period in southern Africa to better understand processes leading to morbidity in adulthood. We conducted a secondary analysis of 945 adolescents aged 8-20 years from urban Malawi and Zimbabwe; we included children with HIV (CWH), an uninfected comparison group from a cohort study, and CWH with co-morbid chronic lung disease (CLD) from a randomised controlled trial. We used latent class analysis of anthropometric Z-scores generated from British 1990 reference equations at two annual time-points, to identify growth trajectory profiles and used multinomial logistic regression to identify factors associated with growth profiles. Growth faltering (one or more of weight-for-age, height-for-age, or BMI-for-age Z-scores < -2) occurred in 38% (116/303) of CWH from the cohort study, 62% (209/336) of CWH with CLD, and 14% (44/306) of HIV-uninfected participants. We identified seven different growth profiles, defined, relatively, as (1) average growth, (2) tall not thin, (3) short not thin, (4) stunted not thin, (5) thin not stunted, (6) thin and stunted and (7) very thin and stunted. Females in profile 3 exhibited the highest body fat percentage, which increased over 1 year. Males at older age and CWH especially those with CLD were more likely to fall into growth profiles 4-7. Improvements in height-for-age Z-scores were observed in profiles 6-7 over 1 year. Interventions to target those with the worst growth faltering and longer-term follow-up to assess the impact on adult health are warranted.

Identifiants

pubmed: 37960240
pii: nu15214589
doi: 10.3390/nu15214589
pmc: PMC10650589
pii:
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : D43 TW009539
Pays : United States

Références

Pediatrics. 2015 May;135(5):e1266-75
pubmed: 25847806
Br J Nutr. 2022 Jun 13;:1-12
pubmed: 35695182
PLoS One. 2018 May 15;13(5):e0196380
pubmed: 29763418
BMC Pediatr. 2010 Aug 06;10:56
pubmed: 20691045
Soc Sci Med. 2018 Oct;214:206-213
pubmed: 30115489
Trials. 2017 Dec 28;18(1):622
pubmed: 29282143
Stat Med. 1998 Feb 28;17(4):407-29
pubmed: 9496720
J Pediatric Infect Dis Soc. 2018 May 15;7(2):143-150
pubmed: 28481997
Front Cardiovasc Med. 2020 Feb 25;7:22
pubmed: 32158768
Am J Clin Nutr. 2013 May;97(5):911-8
pubmed: 23553163
Pan Afr Med J. 2012;11:15
pubmed: 22368758
Am J Hum Biol. 2021 May;33(3):e23469
pubmed: 32808697
Eur J Clin Nutr. 2021 Jan;75(1):189-197
pubmed: 32801307
J Trop Pediatr. 2014 Jun;60(3):179-88
pubmed: 24393831
Curr Opin HIV AIDS. 2018 May;13(3):179-186
pubmed: 29432228
BMJ Open. 2020 Feb 9;10(2):e031792
pubmed: 32041852
JAMA Netw Open. 2020 Dec 1;3(12):e2028484
pubmed: 33331916
Paediatr Int Child Health. 2014 Nov;34(4):250-65
pubmed: 25310000
Pediatr Infect Dis J. 2017 Sep;36(9):869-876
pubmed: 28198792
Adolesc Health Med Ther. 2020 Aug 19;11:101-111
pubmed: 32903856
Nutr Res Rev. 2017 Jun;30(1):50-72
pubmed: 28112064
Nutr Rev. 2009 Jun;67(6):343-59
pubmed: 19519675
Am J Hum Biol. 2010 Jan-Feb;22(1):1-17
pubmed: 19844897
Matern Child Nutr. 2011 Oct;7 Suppl 3:5-18
pubmed: 21929633
J Int AIDS Soc. 2022 Mar;25(3):e25871
pubmed: 35255197
Trop Med Int Health. 2016 May;21(5):619-29
pubmed: 26914715
Acta Biomed. 2021 Feb 16;92(1):e2021168
pubmed: 33682846

Auteurs

Andrea M Rehman (AM)

MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Isaac Sekitoleko (I)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe P.O. Box 49, Uganda.

Ruramayi Rukuni (R)

Department of Clinical Research, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.

Emily L Webb (EL)

MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Grace McHugh (G)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.

Tsitsi Bandason (T)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.

Brewster Moyo (B)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre 312233, Malawi.

Lucky Gift Ngwira (LG)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre 312233, Malawi.
Health Economics Policy Unit, Kamuzu University of Health Sciences, Blantyre 312225, Malawi.

Cynthia Mukwasi-Kahari (C)

The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Celia L Gregson (CL)

Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 1QU, UK.
SAMRC/Wits Developmental Pathways for Health Research Unit, School of Clinical Medicine, University of the Witwatersrand, Johannesburg 2050, South Africa.

Victoria Simms (V)

MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.

Suzanne Filteau (S)

Department of Population Health, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

Rashida A Ferrand (RA)

Department of Clinical Research, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
The Health Research Unit Zimbabwe, Biomedical Research and Training Institute, Harare P.O. Box A178, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH